Literature DB >> 10722747

Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB.

M T Sommerfeld1, R Schweigreiter, Y A Barde, E Hoppe.   

Abstract

This study examines the mechanisms by which the tyrosine kinase receptor TrkB is down-regulated following binding of brain-derived neurotrophic factor (BDNF). In primary cultures of cerebellar granule neurons, BDNF-induced reduction of TrkB receptors was largely prevented by the addition of specific proteasome inhibitors. HN10 cells, a neuronal cell line that can be readily transfected, also showed a marked down-regulation of cell surface TrkB following BDNF exposure. In addition, we observed that prolonged exposure to nerve growth factor of TrkA-transfected cells did not lead to the down-regulation seen with BDNF and TrkB. TrkA and TrkB chimeric molecules were therefore expressed in HN10 cells and tested for ligand-induced regulation. These experiments led to the conclusion that the motives responsible for down-regulation are contained in the cytoplasmic domain of TrkB, and a short sequence in the juxtamembrane domain of TrkB was identified that confers nerve growth factor-induced down-regulation when inserted into TrkA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722747     DOI: 10.1074/jbc.275.12.8982

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Generation of TrkA/TrkB chimeric receptor constructs reveals molecular mechanisms underlying BDNF-induced dendritic outgrowth in hippocampal neurons.

Authors:  Yosuke Sato; Shingo Suzuki; Mako Kitabatake; Tomoko Hara; Masami Kojima
Journal:  Cell Mol Neurobiol       Date:  2011-01-30       Impact factor: 5.046

2.  Regulation of trafficking of activated TrkA is critical for NGF-mediated functions.

Authors:  Tao Yu; Laura Calvo; Begoña Anta; Saray López-Benito; Eileen Southon; Moses V Chao; Lino Tessarollo; Juan C Arévalo
Journal:  Traffic       Date:  2011-02-01       Impact factor: 6.215

Review 3.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

4.  A novel endocytic recycling signal distinguishes biological responses of Trk neurotrophin receptors.

Authors:  Zhe-Yu Chen; Alessandro Ieraci; Michael Tanowitz; Francis S Lee
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

5.  Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury.

Authors:  Arthur J Weber; Suresh Viswanáthan; Chidambaram Ramanathan; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-26       Impact factor: 4.799

6.  Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance.

Authors:  Xuan Li; M R DeJoseph; Janice H Urban; Amine Bahi; Jean-Luc Dreyer; Gloria E Meredith; Kerstin A Ford; Carrie R Ferrario; Jessica A Loweth; Marina E Wolf
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 7.  Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy.

Authors:  Thiri W Lin; Stephen C Harward; Yang Zhong Huang; James O McNamara
Journal:  Neuropharmacology       Date:  2019-08-01       Impact factor: 5.250

Review 8.  Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina.

Authors:  A J Weber; C D Harman; S Viswanathan
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

Review 9.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

10.  Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases.

Authors:  Monika Ray; Jianhua Ruan; Weixiong Zhang
Journal:  Genome Biol       Date:  2008-10-08       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.